Today: 9 April 2026
Rivian stock drops after 2025 delivery update; Feb. 12 earnings now the next test

Rivian stock drops after 2025 delivery update; Feb. 12 earnings now the next test

NEW YORK, January 3, 2026, 07:20 ET — Market closed

  • Rivian shares closed down 1.5% on Friday after the company posted 2025 production and delivery figures.
  • The EV maker said it will report fourth-quarter and full-year results on Feb. 12 after the market close.
  • Investors are watching demand signals as Rivian prepares to launch its lower-priced R2 in 2026.

Rivian Automotive shares closed down 1.5% on Friday at $19.41 after the EV maker posted its quarterly and annual production and delivery update. The stock traded between $18.90 and $20.71 and sits in a 52-week range of $10.36 to $22.69, with shares last at $19.43 in after-hours trading. Investing

The delivery tally matters now because it offers an early read on demand heading into 2026, before Rivian’s next earnings report. Deliveries — vehicles handed to customers — are a key volume gauge for automakers that still burn cash while they scale.

Rivian, which sells the R1T pickup and R1S SUV at premium price points, has been pushing efficiency measures at its Illinois plant and simplifying components to cut material and manufacturing costs, Reuters reported. Demand for higher-priced EVs has softened after the U.S. $7,500 federal EV tax credit expired at the end of September, and analysts had expected 42,500 deliveries in 2025 and 10,050 in the fourth quarter, according to Visible Alpha data cited by Reuters; investors are also looking ahead to Rivian’s smaller, lower-priced R2 SUV expected in the first half of 2026 to take on Tesla’s Model Y. Reuters

In an 8-K — a Securities and Exchange Commission filing used to disclose significant corporate updates — Rivian said it produced 10,974 vehicles and delivered 9,745 in the quarter ended Dec. 31, 2025. For full-year 2025, it produced 42,284 vehicles and delivered 42,247, and said both the quarterly and annual figures were in line with its expectations. Rivian said it will report fourth-quarter and full-year results on Feb. 12 after the market close and host an audio webcast at 5:00 p.m. ET. SEC

The split between production and deliveries will keep attention on inventory and incentives, especially as EV makers compete for buyers at the higher end of the market. Rivian’s results call will show whether cost-cutting efforts are starting to narrow losses.

Investors will be looking for updated targets for 2026 output and deliveries, and for detail on how quickly Rivian can scale a lower-priced platform without giving up margins. Any commentary on order trends and pricing will likely carry outsized weight after a year when volumes slipped.

Canaccord Genuity analyst George Gianarikas reiterated a buy rating and a $21 price target on Rivian, saying his optimism for 2026 “is undiminished” after the delivery update. He flagged the planned R2 rollout in the first half of 2026 as central to the investment case. TipRanks

Before the next session, traders will watch whether the stock can recover key round-number levels after Friday’s slide or whether the delivery print resets expectations into earnings. Thin early-January liquidity can exaggerate moves in high-beta names like EV makers.

The next clear catalyst is Feb. 12, when Rivian is scheduled to report and update guidance — the company’s formal outlook for production, deliveries and costs. That event is also a likely focal point for any refreshed timeline updates tied to the 2026 product roadmap.

Macro data could shape the tape in the meantime. The Labor Department is scheduled to release the December employment report on Jan. 9 at 8:30 a.m. ET and the December consumer price index on Jan. 13 at 8:30 a.m. ET — reports that can move rate expectations and, by extension, rate-sensitive growth stocks. Bureau of Labor Statistics

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:12 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Archer Aviation stock jumps 8% as air-taxi shares rally — what’s driving ACHR now
Previous Story

Archer Aviation stock jumps 8% as air-taxi shares rally — what’s driving ACHR now

China’s 55% beef tariff triggers quota scramble, squeezing Australian wagyu and Angus
Next Story

China’s 55% beef tariff triggers quota scramble, squeezing Australian wagyu and Angus

Go toTop